收藏切换
Clinical research progress of anti-angiogenic tyrosine kinase inhibitors in solid tumors
收藏切换
Rui XU1, Jiajia QIAN1, Cong RUAN1, Qiru WANG1, Qing ZHAI1, 2, 3, *
World Clinical Drug | 2024, 45(7) : 710 - 718
Less
收藏切换
World Clinical Drug | 2024, 45(7): 710-718
• Topic •
Clinical research progress of anti-angiogenic tyrosine kinase inhibitors in solid tumors
Full
Rui XU1, Jiajia QIAN1, Cong RUAN1, Qiru WANG1, Qing ZHAI1, 2, 3, *
Affiliations
  • 1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China
  • 2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
  • 3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
Published: 2024-07-10 doi: 10.13683/j.wph.2024.07.003
Outline
收藏切换

Angiogenesis plays a key role in the growth, local invasion and distant metastasis of a variety of solid tumors. At present, anti-angiogenesis drugs can be divided into three types: small-molecule multi-target, macromolecule single-target and endogenous pan-target angiogenesis inhibitors. Among them, small molecule anti-angiogenesis inhibitors mainly inhibit tumor angiogenesis by simultaneously or sequentially targeting multiple growth factors/pathways, and can effectively inhibit drug resistance generated by tumor cells. At the same time, small molecule anti-angiogenesis inhibitors have the advantages of good tissue permeability and convenient administration. At present, it has been widely used in the combination therapy of various solid tumors. This paper reviewed the targeted therapy of small molecule anti-angiogenic tyrosine kinase inhibitors and their clinical progress and safety in multiple solid tumors.

solid tumors  /  small molecules  /  antiangiogenic inhibitors  /  tyrosine kinase inhibitors
徐蕊, 钱佳佳, 阮聪, 王祺茹, 翟青. 抗血管生成酪氨酸激酶抑制剂在实体瘤中的临床研究进展. 世界临床药物, 2024 , 45 (7) : 710 -718 . DOI: 10.13683/j.wph.2024.07.003
Rui XU, Jiajia QIAN, Cong RUAN, Qiru WANG, Qing ZHAI. Clinical research progress of anti-angiogenic tyrosine kinase inhibitors in solid tumors[J]. World Clinical Drug, 2024 , 45 (7) : 710 -718 . DOI: 10.13683/j.wph.2024.07.003
Year 2024 volume 45 Issue 7
19
6
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.07.003
  • Receive Date:2024-04-30
  • Online Date:2026-11-17
  • Published:2024-07-10
Article Data
Affiliations
History
  • Received:2024-04-30
Funding
Affiliations
    1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China
    2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
    3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.07.003
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT